{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:32:48Z","timestamp":1784734368204,"version":"3.55.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Palmitoylethanolamide (PEA) is an endogenous fatty acid amide that has emerged as a promising therapeutic candidate for neurodegenerative disorders, particularly Alzheimer\u2019s disease (AD). Recognized for its inherent anti-inflammatory, analgesic, immunomodulatory, and neuroprotective properties, PEA possesses a good potential as a novel treatment addressing neuroinflammation associated with neurodegeneration, even though its precise mechanisms of action remain to be fully understood. Dendritic cells (DCs) are specialized migratory innate immune cells that play a crucial role in initiating and regulating immune responses and inflammation in both the body and the brain. In AD, DCs display a dysfunctional, pro-inflammatory profile, suggesting their involvement in disease pathology and progression. To explore the therapeutic potential of PEA, this study investigated its effects\n                    <jats:italic>in vitro<\/jats:italic>\n                    on human monocyte-derived DCs under both normal and AD-like conditions. The results show that PEA exerts significant immunomodulatory effects, promoting the maturation of DCs in both healthy and disease states. Notably, PEA treatment appears to correct the dysregulated state of DCs observed in AD conditions. This study reveals a novel mechanism by which PEA modulates immune activity through its action on DCs. By restoring normal DC function in neurodegenerative settings, PEA may help reduce inflammation, highlighting its potential as a therapeutic agent for Alzheimer\u2019s disease.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1664164","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T05:24:28Z","timestamp":1767331468000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The immunomodulating effect of palmitoylethanolamide on human myeloid dendritic cells and its possible impact on Alzheimer\u2019s disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Iliana","family":"Piccolino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Iannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Lionetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Mazzonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Barreca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerisa","family":"Banaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Arezzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Piras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Boss\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00821","article-title":"Palmitoylethanolamide (PEA) as a potential therapeutic agent in Alzheimer\u2019s disease","volume":"10","author":"Beggiato","year":"2019","journal-title":"Front Pharmacol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041880","article-title":"Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson\u2019s disease","volume":"7","author":"Esposito","year":"2012","journal-title":"PloS One"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-016-0420-z","article-title":"Oral palmitoylethanolamide treatment is associated with reduced cutaneous adverse effects of interferon-\u03b21a and circulating proinflammatory cytokines in relapsing\u2013remitting multiple sclerosis","volume":"13","author":"Orefice","year":"2016","journal-title":"Neurotherapeutics"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2174\/1871527316666170321124949","article-title":"Ultra-micronized palmitoylethanolamide: an efficacious adjuvant therapy for Parkinson\u2019s disease","volume":"16","author":"Brotini","year":"2017","journal-title":"CNSNDDT"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9020428","article-title":"Chronic oral palmitoylethanolamide administration rescues cognitive deficit and reduces neuroinflammation, oxidative stress, and glutamate levels in A transgenic murine model of Alzheimer\u2019s disease","volume":"9","author":"Beggiato","year":"2020","journal-title":"JCM"},{"key":"B6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41398-017-0076-4","article-title":"Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer\u2019s disease by exerting anti-inflammatory and neuroprotective effects","volume":"8","author":"Scuderi","year":"2018","journal-title":"Transl Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2025.1571428","article-title":"Chronic palmitoylethanolamide administration via slow-release subcutaneous pellets promotes neuroprotection and mitigates neuroinflammation in the Tg2576 mouse model of Alzheimer\u2019s disease","volume":"19","author":"Tortolani","year":"2025","journal-title":"Front Cell Neurosci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.1038122","article-title":"Therapeutic effect of palmitoylethanolamide in cognitive decline: A systematic review and preliminary meta-analysis of preclinical and clinical evidence","volume":"13","author":"Colizzi","year":"2022","journal-title":"Front Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf080","article-title":"Phase 2 study of palmitoylethanolamide combined with luteoline in frontotemporal dementia patients","volume":"7","author":"Assogna","year":"2025","journal-title":"Brain Commun"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-\u03b1 Mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Mol Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2014.06.007","article-title":"Harnessing the anti-inflammatory potential of palmitoylethanolamide","volume":"19","author":"Alhouayek","year":"2014","journal-title":"Drug Discov Today"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13580","article-title":"The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations","volume":"174","author":"Petrosino","year":"2017","journal-title":"Br J Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer\u2019s disease","volume":"4","author":"Kinney","year":"2018","journal-title":"A&D Transl Res Clin Interv"},{"key":"B14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-023-00627-2","article-title":"The role of peripheral inflammatory insults in Alzheimer\u2019s disease: a review and research roadmap","volume":"18","author":"Walker","year":"2023","journal-title":"Mol Neurodegeneration"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.6209-10.2011","article-title":"Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer\u2019s disease","volume":"31","author":"Mildner","year":"2011","journal-title":"J Neurosci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"7210","DOI":"10.1038\/s41467-022-34719-2","article-title":"Differential compartmentalization of myeloid cell phenotypes and responses towards the CNS in Alzheimer\u2019s disease","volume":"13","author":"Fern\u00e1ndez Zapata","year":"2022","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41598-017-00342-1","article-title":"Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptor","volume":"7","author":"Guida","year":"2017","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e00300","DOI":"10.1002\/prp2.300","article-title":"The anti-inflammatory compound palmitoylethanolamide inhibits prostaglandin and hydroxyeicosatetraenoic acid production by a macrophage cell line","volume":"5","author":"Gabrielsson","year":"2017","journal-title":"Pharmacol Res Perspect"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.118.311185","article-title":"Palmitoylethanolamide promotes a proresolving macrophage phenotype and attenuates atherosclerotic plaque formation","volume":"38","author":"Rinne","year":"2018","journal-title":"ATVB"},{"key":"B20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12974-019-1514-4","article-title":"A co-ultramicronized palmitoylethanolamide\/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis","volume":"16","author":"Contarini","year":"2019","journal-title":"J Neuroinflamm"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201800107R","article-title":"Bioactive lipids ALIAmides differentially modulate inflammatory responses of distinct subsets of primary human T lymphocytes","volume":"32","author":"Chiurchi\u00f9","year":"2018","journal-title":"FASEB J"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.151085","article-title":"Lipid mediator palmitoylethanolamide (PEA) inhibits pathogenic T cell differentiation in vitro and in vivo","volume":"743","author":"Soga","year":"2025","journal-title":"Biochem Biophys Res Commun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"7363","DOI":"10.1038\/s41598-017-07519-8","article-title":"A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum","volume":"7","author":"Musella","year":"2017","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/biom12081161","article-title":"Synaptic effects of palmitoylethanolamide in neurodegenerative disorders","volume":"12","author":"Assogna","year":"2022","journal-title":"Biomolecules"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4610","article-title":"High-dimensional, single-cell characterization of the brain\u2019s immune compartment","volume":"20","author":"Korin","year":"2017","journal-title":"Nat Neurosci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.immuni.2018.01.011","article-title":"High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease","volume":"48","author":"Mrdjen","year":"2018","journal-title":"Immunity"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2015.11.003","article-title":"Dendritic cells in brain diseases","volume":"1862","author":"Ludewig","year":"2016","journal-title":"Biochim Biophys Acta (BBA)  Mol Basis Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"116258","DOI":"10.1016\/j.bcp.2024.116258","article-title":"Hiding in plain sight: Do recruited dendritic cells surround amyloid plaques in Alzheimer\u2019s disease","volume":"228","author":"Nelson","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00632","article-title":"Myeloid dendritic cells are potential players in human neurodegenerative diseases","volume":"6","author":"Boss\u00f9","year":"2015","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2016.02.009","article-title":"T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer\u2019s disease-like cerebral amyloidosis","volume":"54","author":"Ferretti","year":"2016","journal-title":"Brain Behav Immun"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2007.06.007","article-title":"Amyloid \u03b2 peptide promotes differentiation of pro-inflammatory human myeloid dendritic cells","volume":"30","author":"Ciaramella","year":"2009","journal-title":"Neurobiol Aging"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2010-1257","article-title":"Increased pro-inflammatory response by dendritic cells from patients with Alzheimer\u2019s disease","volume":"19","author":"Ciaramella","year":"2010","journal-title":"JAD"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0483-0","article-title":"Myeloid dendritic cells are decreased in peripheral blood of Alzheimer\u2019s disease patients in association with disease progression and severity of depressive symptoms","volume":"13","author":"Ciaramella","year":"2016","journal-title":"J Neuroinflamm"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.4.1109","article-title":"Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha","volume":"179","author":"Sallusto","year":"1994","journal-title":"J Exp Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS\u2013ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249526","article-title":"Palmitoylethanolamide: A nutritional approach to keep neuroinflammation within physiological boundaries\u2014A systematic review","volume":"21","author":"Petrosino","year":"2020","journal-title":"IJMS"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2022.02.008","article-title":"Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice","volume":"102","author":"Lama","year":"2022","journal-title":"Brain Behav Immun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/futurepharmacol3040058","article-title":"Therapeutic use of palmitoylethanolamide as an anti-inflammatory and immunomodulator","volume":"3","author":"S\u00e1","year":"2023","journal-title":"Future Pharmacol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.376","article-title":"Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer\u2019s disease","volume":"5","author":"Scuderi","year":"2014","journal-title":"Cell Death Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-016-0533-6","article-title":"PEALut efficacy in mild cognitive impairment: evidence from a SPECT case study","volume":"28","author":"Calabr\u00f2","year":"2016","journal-title":"Aging Clin Exp Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4720532","article-title":"Palmitoylethanolamide dampens reactive astrogliosis and improves neuronal trophic support in a triple transgenic model of Alzheimer\u2019s disease: in vitroandIn vivoEvidence","volume":"2018","author":"Bronzuoli","year":"2018","journal-title":"Oxid Med Cell Longevity"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00449-4","article-title":"Dendritic cells","volume":"106","author":"Mellman","year":"2001","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/gtc.12944","article-title":"Comprehensive lipidomics of lupus-prone mice using LC\u2013MS\/MS identifies the reduction of palmitoylethanolamide that suppresses TLR9-mediated inflammation","volume":"27","author":"Ozaki","year":"2022","journal-title":"Genes to Cells"},{"key":"B45","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1365-2567.2008.02842.x","article-title":"Serum lipids regulate dendritic cell CD1 expression and function","volume":"125","author":"Leslie","year":"2008","journal-title":"Immunology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-016840","article-title":"Differentiation of CD1a\u2013 and CD1a+ monocyte-derived dendritic cells is biased by lipid environment and PPAR\u03b3","volume":"109","author":"Gogolak","year":"2007","journal-title":"Blood"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.03.019","article-title":"Extracellular ATP activates P2X7R-NF-\u03baB (p65) pathway to promote the maturation of bone marrow-derived dendritic cells of mice","volume":"119","author":"Yu","year":"2019","journal-title":"Cytokine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1664164\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T05:24:29Z","timestamp":1767331469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1664164\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2025.1664164"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1664164","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"article-number":"1664164"}}